Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pelthos Therapeutics (PTHS) Profit After Tax (2024 - 2025)

Pelthos Therapeutics has reported Profit After Tax over the past 2 years, most recently at -$21.7 million for Q4 2025.

  • Quarterly results put Profit After Tax at -$21.7 million for Q4 2025, down 1024.82% from a year ago — trailing twelve months through Dec 2025 was -$43.3 million (down 444.55% YoY), and the annual figure for FY2025 was -$43.3 million, down 444.55%.
  • Profit After Tax for Q4 2025 was -$21.7 million at Pelthos Therapeutics, down from -$16.2 million in the prior quarter.
  • Over the last five years, Profit After Tax for PTHS hit a ceiling of -$1.7 million in Q3 2024 and a floor of -$21.7 million in Q4 2025.